Testosterone MDL Judge Won’t Reconsider Allowing Adverse Event Testimony By Plaintiffs

Mealey's (July 21, 2017, 11:49 AM EDT) -- CHICAGO — The Illinois judge overseeing the testosterone multidistrict litigation on July 11 refused to reconsider his ruling allowing plaintiff expert Dr. Hossein Ardehali to rely on adverse event reports  (In Re:  Testosterone Replacement Therapy Products Liability Litigation, No. 14-1748, N.D. Ill., 2017 U.S. Dist. LEXIS 106446)....

Attached Documents

Related Sections